Isotretinoin and Long-term Antibiotic Use and Multiple Sclerosis

Basic Details
Date Posted
Thursday, June 30, 2016
Medical Product
long-term antibiotic
Health Outcome(s)
multiple sclerosis

Report 1 is a modular program-based one-time assessment of isotretinoin and long-term antibiotics, including doxycycline, minocycline, and erythromycin, and subsequent multiple sclerosis (MS) diagnoses. Report 2 is a modular program-based one-time assessment of multiple sclerosis diagnoses as defined in three different ways. The queries were run against the Mini-Sentinel Distributed Database (MSDD) for the time period of January 1, 2000 to May 31, 2013.  Modular programs are adaptable standardized programs. Results were generated using Modular Program 3; click here for more information.  Queries were distributed in July 2014. This report includes data from 17 Data Partners.
If you are using a web page screen reader and are unable to access this document, please contact the Mini-Sentinel Operations Center for assistance by clicking on the Submit Comments link above or sending an email requesting assistance to
The information contained on this website is provided as part of FDA's commitment to place knowledge acquired from the Mini-Sentinel pilot in the public domain as soon as possible. Please read the disclaimer.

Additional Details
FDA Center
Time Period
January 1, 2000 - May 31, 2013
Study Type
Modular Program
Assessment Type
Exploratory Analyses
Data Sources
Mini-Sentinel Distributed Database (MSDD)